Significance of serum fibroblast growth factor-23 and miR-208b in pathogenesis of atrial fibrillation and their relationship with prognosis

Table 4 Comparison of serum fibroblast growth factor-23 and miR-208b in patients with and without a major cardiovascular event

Group	n	Man, n (%)	Age (yr)	FGF-23 (ng/mL)	Relative expression of miR-208b
MACE	58	43 (74.14)	61.19 ± 10.54	243.30 ± 72.29	6.12 ± 1.12
Non-MACE	182	125 (68.68)	62.28 ± 9.89	199.65 ± 71.43	5.04 ± 1.07
t		0.624	-0.719	4.041	6.619
P value		0.43	0.473	0.000	0.000

FGF: Fibroblast growth factor; MACE: Major cardiovascular event.